Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL6269201 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL4576505 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL10694663 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL4580568 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Zinc Ion SCHEMBL4582401 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Silver SCHEMBL623539 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL789396 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL22598032 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL19179127 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL28573082 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118040024-B | Composite material, composite solid electrolyte membrane, preparation method and application thereof | 深圳欣界能源科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118040024-A | Composite material, composite solid electrolyte membrane, preparation method and application thereof | 深圳欣界能源科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117477030-A | High-temperature electrolyte of lithium ion battery matched with lithium manganese iron phosphate positive electrode | 复旦大学 | 2024-01-30 | — | — | CN | claimed |
| CN-116632340-A | Lithium ion electrolyte for inhibiting flatulence, preparation method thereof and electrochemical device | 湖南法恩莱特新能源科技有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-115458808-B | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-116097473-B | Electrochemical device and electronic device | 东莞新能源科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4148851-B1 | ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2026-05-13 | — | — | EP | disclosed |
| EP-4468440-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND SECONDARY BATTERY | SHENZHEN CAPCHEM TECHNOLOGY CO LTD (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4443589-B1 | ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND SECONDARY BATTERY WHICH USE SAME | DAIKIN IND LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20260081225-A1 | ELECTROLYTIC SOLUTION AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2026-03-19 | — | — | US | disclosed |
| EP-4704208-A1 | ELECTROLYTE AND BATTERY | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-20220069351-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| CN-112421020-B | Positive electrode material, and electrochemical device and electronic device using same | 宁德新能源科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-114094185-A | Electrolyte solution, electrochemical device, and electronic device | 宁德新能源科技有限公司 | 2022-02-25 | — | — | CN | disclosed |
| CN-114068936-A | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20220052319-A1 | ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2022-02-17 | — | — | US | disclosed |
| US-11063297-B2 | Electrochemical cell and electrolyte for same | Viking Power Systems Pte, Ltd. (SG) | 2021-07-13 | — | — | US | disclosed |
| US-20190198933-A1 | ELECTROCHEMICAL CELL AND ELECTROLYTE FOR SAME | PELLION TECHNOLOGIES INC. (US) | 2019-06-27 | — | — | US | disclosed |
| US-20190198932-A1 | ELECTROCHEMICAL CELL AND ELECTROLYTE FOR SAME | PELLION TECHNOLOGIES INC. (US) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260081225-A1 | ELECTROLYTIC SOLUTION AND BATTERY | HCN1, HCN2, HCN3 | THRB 2422/4885CA1 120/4885CA2 46/4885 |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | THRB 845/4885CA1 167/4885CA2 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.